AN1 0.00% 0.8¢ anagenics limited

AGM, page-2

  1. 12,651 Posts.
    lightbulb Created with Sketch. 1813
    Thought about attending, but not much to discuss really - will wait for updates.

    Newsletter said it all.

    Evolis progressing

    Advangen is primed to take advantage of new hair care megatrend

    Columbia University study shows FGF5 is crucial regulator of human hair loss

    Cxbladder is powering on to become an important test for bladder cancer globally

    Celera-Quest reported progress with its clinical validation of LungDx

    Fujikura has been diligently working on the validation of the test with assistance from Cellmid and
    we expect that the agreement will be signed as soon as costs and quantities can be reliably determined by both parties

    Solid progress in the oncology program

    New Clinical Trial Director, Sarah Culhane
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.